Welcome to our dedicated page for Waystar Holding news (Ticker: WAY), a resource for investors and traders seeking the latest updates and insights on Waystar Holding stock.
Waystar Holding Corp. (Nasdaq: WAY) is a healthcare payment software company whose news flow centers on technology innovation, financial performance, and capital markets activity. As a provider of mission-critical, cloud-native software for healthcare payments, Waystar regularly issues updates about its AI capabilities, platform enhancements, and the impact of its solutions on revenue cycle operations for providers.
Readers of this news page can expect coverage of announcements related to Waystar AltitudeAI™, agentic intelligence, and the company’s broader vision for an autonomous revenue cycle. Recent communications have highlighted how Waystar’s AI-powered platform is used to prevent claim denials, accelerate denial appeals, improve reimbursement recovery, and reduce administrative workload across clinical documentation and billing workflows.
Waystar also reports quarterly and annual financial results, which are typically accompanied by earnings press releases and Form 8-K filings. These updates may include discussions of revenue trends, margins, key operating metrics, and guidance, as well as commentary from management on business performance. In addition, the company announces participation in investor conferences and presentations at major healthcare and technology events, reflecting its engagement with the investment community.
Corporate development and strategic transactions are another important theme in Waystar’s news. The company has announced the acquisition and integration of Iodine Software, describing how the combination of large clinical and financial datasets enhances its AI platform and expands its total addressable market. Index-related news, such as Waystar’s inclusion in the S&P SmallCap 600® Index, also appears in its releases.
For investors, analysts, and healthcare professionals, this news page provides a centralized view of Waystar’s product innovations, AI initiatives, financial disclosures, capital structure developments, and strategic milestones. Regular visits can help readers follow how the company’s software platform and data assets are evolving within the U.S. healthcare payment landscape.
Waystar (NASDAQ:WAY), a healthcare payment software provider, reported strong Q2 2025 financial results with revenue reaching $270.7 million, up 15% year-over-year. The company achieved a net income of $32.2 million with a 12% margin and an adjusted EBITDA of $112.6 million with a 42% margin.
Key performance metrics include 1,268 clients contributing over $100,000 in LTM revenue (up 14% YoY) and a net revenue retention rate of 115%. The company raised its full-year 2025 guidance, projecting revenue between $1.030-1.042 billion and adjusted EBITDA between $418-426 million.
Waystar also announced an agreement to acquire Iodine Software, an AI-powered clinical intelligence company, expected to expand their market reach and be accretive to their financial profile.
Waystar (NASDAQ:WAY) has announced a definitive agreement to acquire Iodine Software for a total enterprise value of $1.25 billion. The acquisition will be funded through a 50/50 mix of cash and stock, with Iodine shareholders receiving approximately 8% ownership of the combined company.
The strategic acquisition aims to enhance Waystar's AI capabilities in healthcare payments, expanding its total addressable market by more than 15%. The deal is expected to be immediately accretive to gross margin and adjusted EBITDA margin, with revenue growth and earnings benefits anticipated by 2027. The company has identified over $15 million in run-rate cost synergies to be realized within 18-24 months post-closing.
Additionally, Waystar reported preliminary Q2 2025 revenue of approximately $271 million, representing 15% year-over-year growth. The transaction is expected to close by year-end 2025.
Waystar Holding Corp. (Nasdaq: WAY), a healthcare payment software provider, has scheduled its Q2 2025 earnings release for July 30, 2025, after market close. The company will host a conference call at 4:30 p.m. Eastern Time on the same day to discuss the financial results.
Investors can access the live audio webcast through Waystar's investor relations website at investors.waystar.com/news-events/events. An archived version of the webcast will be available for those unable to attend the live event.
Waystar (Nasdaq: WAY), a healthcare payment software provider, has been recognized as a 2025-2026 Best Company to Work For by U.S. News & World Report. The company ranked in the top 6% among 5,000 evaluated public companies and within the top 25% in both the Health Care and Research sector and the West region.
The evaluation was based on six key factors: pay and benefits, work-life balance, job stability, physical and psychological comfort, belongingness, and career development. CEO Matt Hawkins highlighted the company's culture of innovation and commitment to simplifying healthcare payments for over one million providers nationwide. Waystar has also received recognition from Fortune's Great Place to Work®, Becker's Healthcare, and the Women Tech Council's Shatter List.
EQT has successfully completed a public offering of Waystar Holding Corp. (NASDAQ: WAY) common stock, generating total gross proceeds of $557.0 million. The offering included approximately 14.4 million shares, with underwriters fully exercising their option to purchase an additional 1.9 million shares. EQT sold about 6.2 million shares, receiving $239.6 million in gross proceeds, while retaining approximately 32.6 million shares. The remaining shares were sold by other stockholders. J.P. Morgan, Goldman Sachs & Co. LLC, and Barclays served as joint book-running managers. Waystar did not sell any shares or receive proceeds from this offering.
Waystar Holding Corp. (Nasdaq: WAY) has announced the pricing of a public offering where certain stockholders, including EQT AB, Bain Capital, and CPP Investments, will sell 12.5 million shares at $38.75 per share. The Selling Stockholders have also granted underwriters a 30-day option to purchase up to 1.875 million additional shares.
The offering, expected to close around May 16, 2025, is being led by J.P. Morgan, Goldman Sachs, and Barclays as joint lead book-running managers. Notably, Waystar itself is not selling any shares and will not receive any proceeds from this offering.
Waystar Holding Corp. (Nasdaq: WAY), a healthcare payments software provider, announced a proposed public offering of 12,500,000 shares of common stock by its major shareholders EQT AB, Bain Capital, LP, and Canada Pension Plan Investment Board. The Selling Stockholders will also grant underwriters a 30-day option to purchase up to 1,875,000 additional shares.
The offering will be led by J.P. Morgan, Goldman Sachs & Co. LLC, and Barclays as joint lead book-running managers. Importantly, Waystar itself is not selling any shares and will not receive any proceeds from the offering. The sale is subject to SEC registration statement effectiveness and other regulatory requirements.
Waystar (Nasdaq: WAY), a healthcare payment software provider, has been named Best Overall Healthcare Payments Solutions Provider by MedTech Breakthrough for the fourth consecutive year. The company's AI-powered platform, including Waystar AltitudeAI™, has demonstrated significant efficiency improvements, reducing denial appeal times by 70% and cutting denial-prevention workflows from three days to three minutes.
Waystar's recent achievements include ranking #1 in eight out of 18 AI categories by Black Book Market Research™, receiving recognition in two revenue cycle categories by Best in KLAS®, and being included in Forbes' inaugural Most Trusted Companies in America list. The company's software solutions serve over one million healthcare providers nationwide, focusing on reducing administrative waste and streamlining healthcare payments.